This is a preview of subscription content, log in via an institution to check access.
Reference
Gao W, et al. A Critical Appraisal and Recommendations for Cost-Effectiveness Studies of Poly(ADP-Ribose) Polymerase Inhibitors in Advanced Ovarian Cancer. PharmacoEconomics : 14 Aug 2020. Available from: URL: https://doi.org/10.1007/s40273-020-00949-9
Rights and permissions
About this article
Cite this article
Recommendations for CEAs of PARP inhibitors for ovarian cancer. PharmacoEcon Outcomes News 860, 29 (2020). https://doi.org/10.1007/s40274-020-7075-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7075-z